Drug Type Antibody drug conjugate (ADC) |
Synonyms E-7974+NCAB-001 (Nanocarrier), NC-6201 |
Target |
Mechanism EGFR modulators(Epidermal growth factor receptor erbB1 modulators), Tubulin inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | JP | - |